SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-052965
Filing Date
2019-10-10
Accepted
2019-10-10 19:08:26
Documents
2
Period of Report
2019-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4681
2 POA DOCUMENT poa.txt EX-24.3_875811 3557
  Complete submission text file 0001209191-19-052965.txt   9650
Mailing Address C/O UNILIFE CORPORATION 250 CROSS FARM LANE YORK PA 17406
Business Address
Kamarck Michael E. (Reporting) CIK: 0001450730 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39083 | Film No.: 191146845

Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)